251 related articles for article (PubMed ID: 25286412)
41. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance.
Sahami-Fard MH; Kheirandish S; Sheikhha MH
Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340
[TBL] [Abstract][Full Text] [Related]
42. A microRNA panel compared to environmental and polygenic scores for colorectal cancer risk prediction.
Raut JR; Schöttker B; Holleczek B; Guo F; Bhardwaj M; Miah K; Schrotz-King P; Brenner H
Nat Commun; 2021 Aug; 12(1):4811. PubMed ID: 34376648
[TBL] [Abstract][Full Text] [Related]
43. Serum miR-92a-1 is a novel diagnostic biomarker for colorectal cancer.
Shi Y; Liu Z
J Cell Mol Med; 2020 Aug; 24(15):8363-8367. PubMed ID: 32562465
[TBL] [Abstract][Full Text] [Related]
44. A three-plasma miRNA panel predicts the risk of colorectal cancer: a community-based nested case‒control study.
Liu J; Chen B; Yang M; Qian Y; Shen Q; Chen H; Dong Y; Wang L; Jiao J
Sci Rep; 2023 Mar; 13(1):4196. PubMed ID: 36918702
[TBL] [Abstract][Full Text] [Related]
45. The role of circulating microRNAs as novel biomarkers in diagnosing colorectal cancer: a meta-analysis.
Rokkas T; Kothonas F; Rokka A; Koukoulis G; Symvoulakis E
Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):819-25. PubMed ID: 25856691
[TBL] [Abstract][Full Text] [Related]
46. Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer.
Liu GH; Zhou ZG; Chen R; Wang MJ; Zhou B; Li Y; Sun XF
Tumour Biol; 2013 Aug; 34(4):2175-81. PubMed ID: 23625654
[TBL] [Abstract][Full Text] [Related]
47. Plasma miRNA can detect colorectal cancer, but how early?
Wikberg ML; Myte R; Palmqvist R; van Guelpen B; Ljuslinder I
Cancer Med; 2018 May; 7(5):1697-1705. PubMed ID: 29573205
[TBL] [Abstract][Full Text] [Related]
48. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
[TBL] [Abstract][Full Text] [Related]
49. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
[TBL] [Abstract][Full Text] [Related]
50. A Highly Predictive Model for Diagnosis of Colorectal Neoplasms Using Plasma MicroRNA: Improving Specificity and Sensitivity.
Carter JV; Roberts HL; Pan J; Rice JD; Burton JF; Galbraith NJ; Eichenberger MR; Jorden J; Deveaux P; Farmer R; Williford A; Kanaan Z; Rai SN; Galandiuk S
Ann Surg; 2016 Oct; 264(4):575-84. PubMed ID: 27471839
[TBL] [Abstract][Full Text] [Related]
51. Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study.
Giráldez MD; Lozano JJ; Ramírez G; Hijona E; Bujanda L; Castells A; Gironella M
Clin Gastroenterol Hepatol; 2013 Jun; 11(6):681-8.e3. PubMed ID: 23267864
[TBL] [Abstract][Full Text] [Related]
52. Identification of serum miR-30a-5p as a diagnostic and prognostic biomarker in colorectal cancer.
Sun Y; Yang B; Lin M; Yu H; Chen H; Zhang Z
Cancer Biomark; 2019; 24(3):299-305. PubMed ID: 30829615
[TBL] [Abstract][Full Text] [Related]
53. Direct S-Poly(T) Plus assay in quantification of microRNAs without RNA extraction and its implications in colorectal cancer biomarker studies.
Niu Y; Xia S; Su M; Dang Q; Kang K; Li L; Gou D
J Transl Med; 2019 Sep; 17(1):316. PubMed ID: 31547825
[TBL] [Abstract][Full Text] [Related]
54. Serum
Wang N; Zeng L; Li Z; Zhen Y; Chen H
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2650-2653. PubMed ID: 31240955
[TBL] [Abstract][Full Text] [Related]
55. Plasma miRNA-based signatures in CRC screening programs.
Zanutto S; Ciniselli CM; Belfiore A; Lecchi M; Masci E; Delconte G; Primignani M; Tosetti G; Dal Fante M; Fazzini L; Airoldi A; Vangeli M; Turpini F; Rubis Passoni GG; Viaggi P; Arena M; Motta RIO; Cantù AM; Crosta C; De Roberto G; Iannuzzi F; Cassinotti A; Dall'Olio V; Tizzoni L; Sozzi G; Meroni E; Bisanti L; Pierotti MA; Verderio P; Gariboldi M
Int J Cancer; 2020 Feb; 146(4):1164-1173. PubMed ID: 31304978
[TBL] [Abstract][Full Text] [Related]
56. Combined serum miR-29c and miR-149 expression analysis as diagnostic genetic markers for colorectal cancer.
Abdul-Maksoud RS; Elsayed RS; Elsayed WSH; Sediq AM; Rashad NM; Shaker SE; Ahmed SM
Biotechnol Appl Biochem; 2021 Aug; 68(4):732-743. PubMed ID: 32678466
[TBL] [Abstract][Full Text] [Related]
57. Colorectal adenoma and carcinoma specific miRNA profiles in biopsy and their expression in plasma specimens.
Nagy ZB; Wichmann B; Kalmár A; Galamb O; Barták BK; Spisák S; Tulassay Z; Molnár B
Clin Epigenetics; 2017; 9():22. PubMed ID: 28289479
[TBL] [Abstract][Full Text] [Related]
58. Serum miR-20a and miR-486 are potential biomarkers for discriminating colorectal neoplasia: A pilot study.
Yang Q; Wang S; Huang J; Xia C; Jin H; Fan Y
J Cancer Res Ther; 2018; 14(7):1572-1577. PubMed ID: 30589041
[TBL] [Abstract][Full Text] [Related]
59. The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer.
Clancy C; Joyce MR; Kerin MJ
Cancer Biomark; 2015; 15(2):103-13. PubMed ID: 25547322
[TBL] [Abstract][Full Text] [Related]
60. Dynamic plasma microRNAs are biomarkers for prognosis and early detection of recurrence in colorectal cancer.
Yuan Z; Baker K; Redman MW; Wang L; Adams SV; Yu M; Dickinson B; Makar K; Ulrich N; Böhm J; Wurscher M; Westerhoff M; Medwell S; Moonka R; Sinanan M; Fichera A; Vickers K; Grady WM
Br J Cancer; 2017 Oct; 117(8):1202-1210. PubMed ID: 28809863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
